"Global Glioblastoma Multiforme Treatment Market  Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 Executive Summary: Global glioblastoma multiforme treatment market size was valued at USD 3.09 billion in 2024 and is projected to reach USD 6.44 billion by 2032, with a CAGR of 8.90% during the forecast period of 2025 to 2032. Surging Demand and...

Polaris Market Research announces the release of its latest research study on Dry Van Container Market Share. The research report examines all the crucial market factors, analyzing the overall market effectively. It integrates a thorough examination of the Dry Van Container market share, size, trends, growth opportunities, latest advancements, and forecast. Also, it offers a depiction of...

The Multiple Myeloma Treatment Market is expected to reach USD 26.5 billion at a CAGR of 4.2% during the forecast period 2022-2030. Multiple myeloma, a complex and incurable hematologic malignancy, poses significant challenges to patients and healthcare providers worldwide. However, recent years have witnessed remarkable strides in the development of novel therapies, reshaping the landscape of...

The Benign Prostatic Hyperplasia Treatment Market Size was valued at USD 11.2 Billion in 2022 and is projected to grow from USD 11.8 Billion in 2023 to USD 18.1 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.50% during the forecast period (2023 - 2032). Benign Prostatic Hyperplasia (BPH) is a prevalent condition among aging men, characterized by the non-cancerous...

AI In Oncology Industry The global AI in oncology market size is expected to reach USD 19.17 billion by 2030, registering a CAGR of 28.92% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness significant growth owing to increasing prevalence of cancer among the global population, propelling the need to develop technologically...

AI in Precision Medicine Market Overview The Global AI in Precision Medicine Market refers to the application of artificial intelligence technologies such as machine learning, deep learning, and natural language processing to personalize healthcare treatment based on individual patient characteristics, genetic makeup, and lifestyle factors. By utilizing AI, precision medicine aims to tailor...

AI-based Clinical Trials Solution Provider Industry The global AI-based clinical trials solution provider market size is expected to reach USD 7.8 billion by 2030, registering a CAGR of 22.1% during the forecast period, according to a new report by Grand View Research, Inc.. AI is a versatile tool and is being increasingly utilized to improve the operational efficacy of drug studies...

Ace Therapeutics, a leading innovator in preclinical research models, has unveiled a suite of customizable in vivo and in vitro models designed to accelerate Alzheimer’s disease (AD) drug development. With neurodegenerative disorders posing a growing global health challenge, Ace Therapeutics’ advanced platforms provide researchers with highly predictive, translatable tools to...

Ace Therapeutics, a leading preclinical research organization, unveils its specialized nephrology-focused preclinical solutions to accelerate kidney disease drug development. With a comprehensive suite of validated models and cutting-edge technologies, Ace Therapeutics empowers researchers and biopharma companies to overcome challenges in renal drug discovery and translation. Kidney disease...

Acquired Aplastic Anemia (AAA) is a rare condition where the bone marrow fails to produce enough blood cells, leading to a variety of symptoms such as fatigue, increased risk of infections, and uncontrolled bleeding. It occurs due to immune system dysfunction, which targets the body’s own bone marrow cells. The exact cause of acquired aplastic anemia can vary, but it is often triggered by...